Notably, proteomic analysis of exosomes released from colorectal cancer cells has identified the presence of EpCAM on those microvesicles (56, 86), and in bladder cancer, urinary soluble EpCAM levels were detected and increased with stage and grade of the tumor (10). Here, EPCAM is linked to urinary bladder carcinoma.